Is Paladin Energy Ltd set to trump Fortescue Metals Group Limited?

Uranium hopeful Paladin Energy Ltd (ASX:PDN) could successfully issue bonds when Fortescue Metals Group Limited (ASX:FMG) can't. There's two important takeaways from this that investors should know.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Uranium miner Paladin Energy Ltd (ASX: PDN) jumped to a three-week high after it pulled off what Australia's third largest iron ore producer could not.

Paladin said today that it sold $US50 million in convertible bonds to sovereign wealth fund, China Investment Corporation (CIC), and that help send the stock racing 2.6% higher to 39.5 cents.

The bond sale comes a week after Fortescue Metals Group Limited (ASX: FMG) failed to sell $US2.5 billion in bonds to help retire debt due to questions about its credit worthiness as iron ore prices collapsed.

There are two important consequences we can glean from this that I'll talk about this later.

Coming back to Paladin, this is actually the second tranche of bonds that Paladin has managed to sell this year. Paladin raised $US100 million from professional and sophisticated investors last month at an interest (or coupon) rate of 7% with the bonds maturing in 2020.

CIC's interest is not surprising. As I reported a week ago, China is restarting the construction of new nuclear power plants after these plans were shelved following the Fukushima disaster.

About $US100 million of the $US150 million raised will be used to repurchase $US300 million in convertible bonds that mature in November this year.

While Paladin will be paying more in interest as the maturing bonds have a coupon of 3.625%, it is still a good outcome given the risk profile of the small cap uranium miner.

BHP Billiton Limited (ASX: BHP) is also looking to raise cash through an Australian dollar bond offering. Fairfax reported that it could issue $500 million to $1 billion at a 3.25% coupon, which would make this the cheapest bond offering in the country.

BHP is in a totally different class to Paladin, but what this says to me is that yield-hungry income investors are happy to lend money to companies that are facing challenging outlooks as long as the business is seen to be sustainable in the current down cycle.

The fact is investors have already gotten their fill on debt securities issued by the big banks and are hungry to diversify into other sectors.

This has long been the issue with the Australian credit market, which at times only seems to be serviced by bank bonds and hybrids.

I suspect we will be seeing more bond issues from outside the financial sector, and even among small caps.

Already personal and household goods supplier McPherson's Ltd (ASX: MCP) is paving the way with a $60 million corporate bond offering that was announced last Friday.

The second and more significant takeaway is for equity investors to be wary of where credit investors fear to tread – by that I mean to be cautious about investing in a company that cannot attract credit investors.

This is because credit investors are a different breed to equity investors. The former is far more focused on analysing the downside to limit risk while share investors tend to concentrate on the upside or how much money they can make.

Fortescue may be reassuring investors that it is under no debt pressure, but the fact that credit investors are willing to lend money to a $650 million market cap uranium miner and not a $6.2 billion iron ore producer says something else altogether.

Motley Fool contributor Brendon Lau owns shares in BHP. Follow me on Twitter - https://twitter.com/brenlau

The Motley Fool’s purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool’s free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead.  This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »